Technology, Current


1nhaler has developed a proprietary Dry Powder Inhaler (“DPI”) using unique membrane technology to deliver respiratory and inhalable drugs. It aims to deliver the world’s smallest, simplest, and most sustainable single dose inhaler.

Existing dry powder multi-dose inhalers are expensive and not suitable for some medical conditions that need single, irregular doses of medicines.  Current single dose inhalers are limited as they are bulky and complex to use for patients.  They are also made from plastic and the industry is moving away from plastics and products that contain greenhouse gases.

Year of investment



Sarah Hardy

Seeking investment?

Our team is always actively seeking new investment opportunities. They review circa 200 business plans each year.

Become a member

Our members are genuinely motivated to give something back and build great businesses in Scotland, as well as making a financial return.

We use cookies to give you the best experience. Cookie Policy

Preloader image